Intrinsic Value

The intrinsic value of Eckert & Ziegler SE (EUZ) under the Base Case is 20.18 EUR per share. Compared with the current market price of 13.43 EUR, the stock appears Undervalued by 33% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

EUZ Intrinsic Value
€20.18
Undervaluation 33%
Intrinsic Value
Price €13.43

EUZ is cheaper than usual. It was this cheap or cheaper on just 17% of days in the past 5 years.

Monitor EUZ
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €16.15
Get notified when the price drops into your buy zone
Intrinsic Value €20.18
Margin of Safety 20% €16.15
Current Price €13.43
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to EUZ

Fundamental Analysis

What Eckert & Ziegler Does

Health Care

Eckert & Ziegler Strahlen und Medizintechnik makes radioactive components and radiation-based products used in medicine, research, and industry. Its core business includes sealed radiation sources, calibration standards, brachytherapy seeds, and radioisotope materials that help doctors diagnose and treat disease and help labs and equipment makers measure radiation correctly.

Headquarters
Germany DE
Employees
1 100
IPO date
May 25, 1999
Read the full company overview
View Company Overview

Eckert & Ziegler has no economic moat

No Moat Narrow Wide

Eckert & Ziegler SE lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Eckert & Ziegler SE

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one EUZ stock?

The intrinsic value for Eckert & Ziegler SE (EUZ) under the Base Case is 20.18 EUR.

Is EUZ stock undervalued or overvalued?

Compared with the current market price of 13.43 EUR, the stock appears Undervalued by 33% .

Back to Top